secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001493152-26-013836
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab reports fiscal 2025 net income of $457K, revenue up 26% to $2.69M
------------------------------------------------------------------------

- Revenue $2.69M (+26% YoY); net income $457,417 vs net loss $259,239 in 2024.
- Gross margin expanded to 67.3% from 63.7%; gross profit $1.81M vs $1.36M.
- Current liabilities reduced to ~$450K from ~$2.4M; cash increased to $636K from $157K.
- ISP revenue grew 74% YoY to $1.12M; immunotherapy sales up ~19%.
- Recorded ~$1.15M gain on extinguishment of convertible debt; interest expense halved to $237K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315226013836/0001493152-26-013836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315226013836/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-013836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer